ConcertAI’s TeraRecon, advanced visualization and AI Clinical SaaS category leader, has announced its Eureka Clinical AI platform is now available to European healthcare providers. The company initiated distribution agreements with seven leading CE-marked AI software developers —Cercare Medical, Combinostics, Coreline Soft, Imaging Biometrics (CE pending), Infervision, Radiobotics, and Riverain Technologies. Eureka Clinical AI is now one of the leading unified solutions for clinical AI algorithms in Europe, providing clinical and diagnostic benefits across radiology, neurology, oncology, pulmonology, and cardiology.
Through the partnership agreements, Clinical AI applications available in the EU market include:
- Cercare Medical’s Cercare Perfusion is a fully-automated, patient-specific perfusion application for brain CT and MRI that provides deep insight into brain tissue oxygenation through standard and unique perfusion biomarkers.
- Combinostics cMRI goes beyond MRI quantification to provide automated, objective quantification, lesion assessment and biomarker-based diagnostic support for dementia, Multiple Sclerosis, Traumatic Brain Injury and Epilepsy.
- Coreline Soft AVIEW CAC automatically segments and displays the location of calcified lesions in CT chest exams to assist clinicians in the early detection of coronary artery disease. Also offered, AVIEW LCS automatically detects and segments lung nodules in CT scans for lung cancer screening, and provides optimized workflow based on Lung-RADS. AVIEW LCS is available as a standalone application, or in combination with AVIEW CAC and/or an LAA analysis algorithm to meet your specific needs.
- Imaging Biometrics IB Clinic provides MR perfusion imaging for brain tumor analysis with key physiological information like true regions of contrast enhancement (void of post-surgical blood products), and tumor blood volume and flow. (CE pending)
- Infervision InferRead Lung CT.AI aids in the quick and accurate detection and quantification of lung nodules, and auto-routes all data to PACS, EMR, and reporting systems.
Eureka Clinical AI is unique in the industry for its open AI approach that supports the hosting and management of first-party algorithms; proprietary TeraRecon solutions such as TR Neuro, an AI-assisted workflow solution purposely built for the detection and care activation of neurovascular emergencies.; and third-party solutions. ConcertAI CEO, Jeff Elton, PhD commented “ConcertAI and TeraRecon have the broadest array of clinical and AI solutions in production globally.
SOURCE: PR Newswire